tldrdailynews.com logo

FDA awards nine companies priority review vouchers for expedited drug approvals

1 min read
Source: BioPharma Dive
FDA awards nine companies priority review vouchers for expedited drug approvals
Photo: BioPharma Dive
TL;DR

The FDA has awarded nine companies, including Regeneron and Revolution Medicines, a new 'national priority' voucher to expedite drug reviews, potentially reducing evaluation time to one or two months for treatments addressing urgent health needs, with the program currently limited to select drugs meeting specific criteria.

Topics:businesshealthcare#biotech#drug-review#fda#healthcare#priority-voucher#regulatory-acceleration
Share this article
  1. FDA awards 9 companies a new ‘national priority’ voucher to speed drug reviews  BioPharma Dive
  2. FDA unveils drugs to receive expedited review in support of ‘national priorities’  AP News
  3. US FDA announces recipients of national priority vouchers  Reuters
  4. FDA unveils nine drugs getting streamlined reviews  Axios
  5. FDA names 9 first recipients of 1- to 2-month priority review vouchers  Fierce Biotech

Want the full story? Read the original reporting

Read on BioPharma Dive